Last reviewed · How we verify
NCT04017312
A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting
NA trial testing High Frequency Chest Wall Oscillation in Bronchiectasis in 43 participants. Terminated before completion.
6 August 2024
Quick facts
| Lead sponsor | Hill-Rom |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 23 August 2019 |
| Primary completion | 6 August 2024 |
| Estimated completion | 6 August 2024 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- High Frequency Chest Wall Oscillation
- Oscillating Positive Expiratory Pressure (OPEP)
Conditions studied
- Bronchiectasis — all drugs for Bronchiectasis →
- Bronchiectasis With Acute Exacerbation — all drugs for Bronchiectasis With Acute Exacerbation →
Sponsor
Hill-Rom
Who can join
Adults 18 to 80, any sex, with Bronchiectasis or Bronchiectasis With Acute Exacerbation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This a 70 patient multi-site non blinded randomized control trial evaluating the use of the Vest® System for treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting. The study will assess outcomes in subjects requiring airway clearance therapy randomized to Oscillating Positive Expiratory Pressure (OPEP) therapy as the control group and High Frequency Chest Wall Oscillation (HFCWO) therapy as the intervention group
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04017312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High Frequency Chest Wall Oscillation
Trials testing the same drug.
- NCT04947436 — ALS and Airway Clearance (ALSAC) Therapy · NA · completed
Other recruiting trials for Bronchiectasis
Currently open trials in the same condition.
- NCT07283497 — Itraconazole Therapy In Bronchiectasis With Airway Mold · Phase 4 · recruiting
- NCT07188675 — Functional Inspiratory Training in Bronchiectasis · NA · recruiting
- NCT06897761 — Development of an Interactive Digital Respiratory Game and Device and Investigation of Its Effectiveness in Children Wit · NA · recruiting
- NCT07147803 — Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis · active not recruiting
- NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
Other Hill-Rom trials
Trials by the same sponsor.
- NCT04627272 — AutoDx-DR Prospective Clinical Validation Study Protocol · NA · unknown
- NCT04582214 — Oscillation and Lung Expansion Therapy in Patients With COVID-19 · NA · unknown
- NCT03645473 — Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System · NA · unknown
- NCT03628833 — Incontinence Management System ICU Field Evaluation · NA · completed
- NCT03463434 — AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04017312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hill-Rom
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing